USMLE Step 2 CK practice question: High-risk febrile neutropenia after AML induction: empiric IV cefepime within 1 hour
USMLE Step 2 CKHematology/OncologyInternal Medicine
Which of the following is the most appropriate empiric antimicrobial therapy?
- Oral ciprofloxacin plus amoxicillin-clavulanate as an outpatient
- IV ceftriaxone monotherapy
- IV cefepime monotherapy
- IV vancomycin plus micafungin
- No antibiotics until blood cultures grow an organism
Show answer and explanation
Correct answer: C. IV cefepime monotherapy
Fever (a single oral temperature of 38.3°C [101°F] or higher, or 38.0°C [100.4°F] or higher sustained for 1 hour) with an absolute neutrophil count below 500/mm³, or expected to fall below 500/mm³ within 48 hours, is febrile neutropenia, a medical emergency. This patient is high risk: profound neutropenia (100/mm³ or less) that is expected to last more than 7 days after AML induction. High-risk patients are admitted and given empiric IV monotherapy with an antipseudomonal beta-lactam, such as cefepime, piperacillin-tazobactam, or a carbapenem (meropenem), within 60 minutes of presentation, after blood cultures are drawn but without waiting for results. Neutropenic patients may show few signs of infection, and gram-negative bacteremia, especially with Pseudomonas aeruginosa, can progress to septic shock within hours.
Vancomycin is not routine; it is added for hemodynamic instability, suspected catheter-related infection, skin or soft-tissue infection, pneumonia, known MRSA colonization, or severe mucositis in a patient on fluoroquinolone prophylaxis. Empiric antifungal therapy is considered for fever that persists 4 to 7 days despite antibiotics. Low-risk patients (for example, a MASCC score of 21 or higher and a short expected duration of neutropenia) may be treated with oral ciprofloxacin plus amoxicillin-clavulanate.
Why the other options are wrong
- A. Oral ciprofloxacin plus amoxicillin-clavulanate as an outpatient — Oral outpatient therapy is limited to low-risk patients; profound, prolonged neutropenia after AML induction is high risk.
- B. IV ceftriaxone monotherapy — Ceftriaxone lacks reliable activity against Pseudomonas aeruginosa, a key pathogen to cover in febrile neutropenia.
- D. IV vancomycin plus micafungin — This combination lacks gram-negative coverage; vancomycin is added only for specific indications, and antifungals for persistent fever.
- E. No antibiotics until blood cultures grow an organism — Delaying antibiotics until cultures turn positive increases mortality; empiric therapy must start within 60 minutes.
Key point
High-risk febrile neutropenia requires empiric IV antipseudomonal beta-lactam monotherapy, such as cefepime, within 1 hour of presentation.
Memory hook
Neutropenic fever is a 60-minute emergency: cultures, then cefepime (or piperacillin-tazobactam or meropenem). Vancomycin needs a specific reason.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free